Immunic announces 1-for-10 reverse stock split effective April 27, 2026

IMMUNIC, INC.

Reverse stock split at 1-for-10 ratio; reduces outstanding shares from ~136M to ~13.6M.
Effective 12:01 a.m. ET on April 27, 2026; trading on Nasdaq (IMUX) begins split-adjusted same day.
New CUSIP: 4525EP200; no fractional shares issued, cash in lieu for fractional amounts.
Board determined ratio after stockholder approval on April 14, 2026.
Split intended to meet contractual obligations under Feb 12, 2026 securities purchase agreement.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

IMMUNIC, INC.: Certificate of Amendment filed to effect a 1-for-10 reverse stock split, combining every 10 shares of common stock into 1 share (effective 2026-04-22).

Change: charter amendment
Effective: 2026-04-22

Exact text from the filing

On April 22, 2026, the Company filed a Certificate of Amendment (the “Certificate of Amendment”) to amend the Company’s certificate of incorporation, as amended and restated (the “Charter”), with the Secretary of State of the State of Delaware to effect the Reverse Stock Split at a 1-for-10 ratio

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

IMMUNIC, INC. filing history →

Source: SEC EDGAR

accession 0001193805-26-000495

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.